Eman O Osman

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Molecular Docking

Cell Cycle Arrest

Anti Inflammatory

Top Venues

Drug development research

RSC medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Eman O Osman, Nadia A Khalil, Alaa Magdy, Yara El-Dash
New pyrazole-pyridazine hybrids as selective COX-2 inhibitors: design, synthesis, molecular docking, in silico studies and investigation of their anti-inflammatory potential by evaluation of TNF-α, IL-6, PGE-2 and NO in LPS-induced RAW264.7 macrophages. RSC medicinal chemistry 15 (8) (2024)
Eman O Osman, Nadia A Khalil, Alaa Magdy, Yara El-Dash
Pyridazine and pyridazinone derivatives: Synthesis and in vitro investigation of their anti-inflammatory potential in LPS-induced RAW264.7 macrophages. Drug development research 85 (2) (2024)
Eman O Osman, Nadia A Khalil, Alaa Magdy, Yara El-Dash
New pyrazole-pyridazine hybrids as selective COX-2 inhibitors: design, synthesis, molecular docking, in silico studies and investigation of their anti-inflammatory potential by evaluation of TNF-α, IL-6, PGE-2 and NO in LPS-induced RAW264.7 macrophages. RSC medicinal chemistry 15 (8) (2024)
Eman O Osman, Soha H Emam, Amr Sonousi, Mai M Kandil, Amr M Abdou, Rasha A Hassan
Design, synthesis, anticancer, and antibacterial evaluation of some quinazolinone-based derivatives as DHFR inhibitors. Drug development research (2023)
Soha H Emam, Rasha A Hassan, Eman O Osman, Mohammed I A Hamed, Amr M Abdou, Mai M Kandil, Eman Maher Elbaz, Demiana S Mikhail
Coumarin derivatives with potential anticancer and antibacterial activity: Design, synthesis, VEGFR-2 and DNA gyrase inhibition, and in silico studies. Drug development research (2023)